Citation Impact
Citing Papers
Preliminary clinical observations with recombinant interleukin-2 in patients with AIDS or LAS
1985
Alternative Activation Is an Innate Response to Injury That Requires CD4+ T Cells to be Sustained during Chronic Infection
2007 StandoutNobel
Cytokines in inflammatory bowel disease
2014 Standout
Leishmaniasis
2018 Standout
Intradermal Recombinant Interleukin 2 Enhances Peripheral Blood T‐Cell Responses to Mitogen and Antigens in Patients with Lepromatous Leprosy
1990
Canine leishmaniosis – new concepts and insights on an expanding zoonosis: part one
2008 Standout
Antigen-induced Proliferative Response of Lavage and Blood T Lymphocytes: Comparison of Cells from Normal Subjects and Patients with Sarcoidosis
1991
Endothelial cells and the pathogenesis of lepromatous neuritis:insights from the armadillo model
2000
Electrophysiological classification of guillain‐barré syndrome: Clinical associations and outcome
1998 Standout
Prize‐winning paper Jubilee Competition: Canine leishmaniasis
1988
Topical treatment of New and Old World cutaneous leishmaniasis in experimental animals
1987
Outbreak of cutaneous leishmaniasis in Silti woreda, Ethiopia: risk factor assessment and causative agent identification
2008
Defining protective responses to pathogens: cytokine profiles in leprosy lesions
1991 StandoutScience
Guillain-Barré syndrome
2016 Standout
Genetic variability within the species Leishmania aethiopica does not correlate with clinical variations of cutaneous leishmaniasis
2000
Cutaneous leishmaniasis
2007 Standout
Naturally Arising CD25+CD4+ Regulatory T Cells in Tumor Immunity
2005 StandoutNobel
Administration of Recombinant Interleukin-2 Reduces the Local Parasite Load of Patients with Disseminated Cutaneous Leishmaniasis
1990
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
EBNA1-specific CD4+ T cells in healthy carriers of Epstein-Barr virus are primarily Th1 in function
2001 StandoutNobel
Localization of Mycobacterium leprae to Endothelial Cells of Epineurial and Perineurial Blood Vessels and Lymphatics
1999
LeishVet guidelines for the practical management of canine leishmaniosis
2011 Standout
Sarcoidosis
1997 Standout
Leprosy
2004 Standout
New use of BCG for recombinant vaccines
1991 StandoutNature
Immune Mechanisms in Inflammatory Polyneuropathya
1988
Inflammatory bowel disease: Etiology and pathogenesis
1998 Standout
The Pathophysiology of Rhinitis: II. Assessment of the Sources of Protein in Histamine-induced Nasal Secretions
1989
The efficacy of enrofloxacin, alone or combined with metronidazole, in the therapy of canine leishmaniasis
2004
Myelin changes in leprous neuropathy
1987
Enhanced Interleukin‐10 Production in Response toMycobacterium aviumProducts in Mononuclear Cells from Patients with Human Immunodeficiency Virus Infection
1998
Local and Systemic Effects of Intradermal Recombinant Interferon-γ in Patients with Lepromatous Leprosy
1986 StandoutNobel
Impaired resistance to Mycobacterium tuberculosis infection after selective in vivo depletion of L3T4+ and Lyt-2+ T cells
1987
The Immunology of Leprosy: Speculations on the Leprosy Spectrum
1981
Sequestration From Immune CD4 + T Cells of Mycobacteria Growing in Human Macrophages
1993 StandoutScienceNobel
Immunology of Tuberculosis
2001 Standout
A retrospective clinical study of canine leishmaniasis in 150 dogs naturally infected by Leishmania infantum
1997
Induction of Tumor Immunity by Removing CD25+CD4+ T Cells: A Common Basis Between Tumor Immunity and Autoimmunity
1999 StandoutNobel
T‐cell receptor signaling and the pathogenesis of autoimmune arthritis: insights from mouse and man
2012 StandoutNobel
Cellular immunity in lepromatous and tuberculoid leprosy
1985
Defective gamma interferon production in leprosy. Reversal with antigen and interleukin 2.
1983 StandoutNobel
Influence of Mycobacterium leprae and its soluble products on the cutaneous responsiveness of leprosy patients to antigen and recombinant interleukin 2.
1989
Rhodococcus equi: an animal and human pathogen
1991 Standout
ROLE OF CYTOKINES IN RHEUMATOID ARTHRITIS
1996 Standout
T cell subsets in leprosy lesions: in situ characterization using monoclonal antibodies.
1983
Anti-L3T4 antibody treatment suppresses hepatic granuloma formation and abrogates antigen-induced interleukin-2 production in Schistosoma mansoni infection
1986
Activating Receptors and Coreceptors Involved in Human Natural Killer Cell-Mediated Cytolysis
2001 Standout
Serological specificity of phenolic glycolipid I from Mycobacterium leprae and use in serodiagnosis of leprosy
1983
Influence of delayed immune reactions on human epidermal keratinocytes.
1986 StandoutNobel
BCG vaccination in leprosy: final results of the trial in Karimui, Papua New Guinea, 1963-79.
1989
HLA and Susceptibility to Leprosy
1983
Zanvil Alexander Cohn 1926-1993.
1994 StandoutNobel
Common themes in microbial pathogenicity revisited
1997 Standout
Progress in the immunology of the mycobacterioses.
1987
Differing Lymphokine Profiles of Functional Subsets of Human CD4 and CD8 T Cell Clones
1991 StandoutScience
A role for natural antibody in the pathogenesis of leprosy: antibody in nonimmune serum mediates C3 fixation to the Mycobacterium leprae surface and hence phagocytosis by human mononuclear phagocytes
1994
The Cutaneous Infiltrates of Leprosy
1982 StandoutNobel
Selective Primary Health Care: Strategies for Control of Disease in the Developing World. V. Leprosy
1983
Defective production of monocyte-activating cytokines in lepromatous leprosy.
1984
An approach to isolating T cell lines that react to antigens presented on the surface of dendritic cells
1991 StandoutNobel
Interleukin-10 and the Interleukin-10 Receptor
2001 Standout
Hansen's disease as a research model.
1984
Suppression of T-cell proliferation by Mycobacterium leprae and its products: the role of lipopolysaccharide.
1990
An analysis of in vitro T cell responsiveness in lepromatous leprosy.
1985 StandoutNobel
The reconstitution of cell-mediated immunity in the cutaneous lesions of lepromatous leprosy by recombinant interleukin 2.
1989
Cryptosporidium spp. and cryptosporidiosis
1986 Standout
Selective correlation of interferon‐γ, tumour necrosis factor‐α and granulocyte–macrophage colony‐stimulating factor with immunoglobulin G1 and immunoglobulin G3 subclass antibody in leprosy
1999
Teased fibre studies in leprous neuropathy
1987
Genetically restricted suppressor T-cell clones derived from lepromatous leprosy lesions
1986 Nature
Accessory cell heterogeneity in lepromatous leprosy; dendritic cells and not monocytes support T cell responses.
1989
T-cell abnormalities in inflammatory bowel disease are mediated by interleukin 2
1984
Interleukin-2 reverses deficient cell-mediated immune responses in rheumatoid arthritis.
1984
Surviving the Acid Test: Responses of Gram-Positive Bacteria to Low pH
2003 Standout
Definition of a human suppressor T-cell epitope.
1994
Cancer Immunotherapy Using Interleukin-2 and Interleukin-2-Activated Lymphocytes
1986
Drug Resistance in Leishmaniasis
2006 Standout
Inhibition of the proliferative response of peripheral blood lymphocytes to mycobacterial or fungal antigens by co-stimulation with antigens from various mycobacterial species.
1981
In situ characterization of T lymphocyte subsets in the reactional states of leprosy.
1983
A recombinant 64 kilodalton protein of Mycobacterium bovis bacillus Calmette-Guerin specifically stimulates human T4 clones reactive to mycobacterial antigens.
1986
Presentation of mycobacterial antigens by human dendritic cells: lack of transfer from infected macrophages
1993 StandoutNobel
The Continuing Challenges of Leprosy
2006 Standout
Crohn's disease and the mycobacterioses: a review and comparison of two disease entities
1989
Mycobacterium leprae fails to stimulate phagocytic cell superoxide anion generation
1986
Works of A Belehu being referenced
Leishmania in the Old World: 3. The distribution of L. aethiopica zymodemes
1986
Immune responses to bovine neural antigens in leprosy patients. II. Absence of in vitro lymphocyte stimulation to peripheral nerve myelin proteins
1983
Nerve damage following intraneural injection of Mycobacterium leprae into rabbits pre-sensitized to mycobacteria.
1983
Immunoglobulin A (IgA) in nasal washings and saliva of leprosy patients.
1983
Demonstration of mycobacterial antigens in nerve biopsies from leprosy patients using peroxidase-antiperoxidase immunoenzyme technique
1983
Leishmaniasis: hematologic aspects.
1982
Humoral immunity in leprosy: immunoglobulin G and M antibody responses to Mycobacterium leprae in relation to various disease patterns
1982
Effect of Mycobacterium leprae on lymphocyte proliferation: suppression of mitogen and antigen responses of human peripheral blood mononuclear cells.
1980
Thymus dependent lymphocytes in leprosy. I. T lymphocyte subpopulations defined by monoclonal antibodies.
1982
Failure of metronidazole treatment in Ethiopian mucocutaneous leishmaniasis
1978
Immunoglobulin class specific antibodies to M. leprae in leprosy patients, including the indeterminate group and healthy contacts as a step in the development of methods for sero-diagnosis of leprosy.
1982
Studies on the Defect in Cell‐Mediated Immunity in Lepromatous Leprosy using HLA‐D‐Identical Siblings
1982
Immunopathological aspects of leishmaniasis
1980
ANTIGEN-SPECIFIC SUPPRESSOR CELLS IN SUBCLINICAL LEPROSY INFECTION
1981
Borderline tuberculoid leprosy following BCG vaccination. A case report.
1981
IN-VITRO LYMPHOPROLIFERATIVE RESPONSE TO MYCOBACTERIUM LEPRÆ OF HLA-D-IDENTICAL SIBLINGS OF LEPROMATOUS LEPROSY PATIENTS
1978
T-cell conditioned media reverse T-cell unresponsiveness in lepromatous leprosy
1983 Nature
Immune responses to bovine neural antigens in leprosy patients. I. Absence of antibodies to an isolated myelin protein.
1983
Relation between anti-Mycobacterium leprae antibody activity and clinical features in borderline tuberculoid (BT) leprosy.
1983
Electron microscopical studies on cutaneous leishmaniasis in Ethiopia
1982
In Vitro Stimulation of Lymphocytes in Leprosy Patients, Healthy Contacts of Leprosy Patients, and Subjects Not Exposed to Leprosy
1982